These cambinol analogs exhibited on-target Sirt2 inhibition in the NCI-H60 NSCLC cell line, as demonstrated by a concentration-dependent increase in α-tubulin acetylation [138]. The gene discussed is SIRT2; the disease is non-small cell lung carcinoma.